Redx Pharma plc
REDX.LDrugs in Pipeline
3
Phase 3 Programs
0
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
0 upcoming, 0 past
No catalysts found.
Frequently asked questions
What is in Redx Pharma plc's drug pipeline?→
CatalystAlert tracks 3 drug candidates in Redx Pharma plc's (REDX.L) pipeline across Phase 2. Its lead program is Denosumab (Phase 2). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Redx Pharma plc's next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for Redx Pharma plc (REDX.L) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track REDX.L biotech catalysts?→
Add REDX.L to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Redx Pharma plc's live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.